Overview of Dr. Topkara
Dr. Veli Topkara is a cardiologist in Madison, WI and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Hacettepe University Faculty of Medicine and has been in practice 21 years. He is one of 697 doctors at New York-Presbyterian Hospital and one of 322 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Cardiology. He has more than 100 publications and over 500 citings.
Office
600 Highland Ave
Madison, WI 53792Fax+1 608-265-1918
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Advanced Heart Failure and Transplant Cardiology, 2013 - 2014
- Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 2009 - 2013
- Baylor College of MedicineResidency, Internal Medicine, 2006 - 2009
- Sidney Kimmel Medical College at Thomas Jefferson UniversityInternship, Transitional Year, 2005 - 2006
- Hacettepe University FOMClass of 2003
Certifications & Licensure
- NY State Medical License 2013 - 2026
- WI State Medical License 2024 - 2025
- MO State Medical License Active through 2013
- PA State Medical License 2005 - 2006
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 8 citationsImpact of Pretransplant Malignancy on Heart Transplantation Outcomes: Contemporary United Network for Organ Sharing Analysis Amidst Evolving Cancer Therapies.Jaya Batra, Ersilia M DeFilippis, Stephanie Golob, Kevin Clerkin, Veli K Topkara
Circulation. Heart Failure. 2022-04-01 - 365 citationsRight Heart Failure After Left Ventricular Assist Device Implantation in Patients With Chronic Congestive Heart FailureNicholas C. Dang, Veli K. Topkara, Michelle L. Mercando, Joy Kay, Kurt H. Kruger
The Journal of Heart and Lung Transplantation. 2006-01-01 - 62 citationsGut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant.Melana Yuzefpolskaya, Bruno Bohn, M. Nasiri, A.M. Zuver, Drew D. Onat
The Journal of Heart and Lung Transplantation. 2020-02-13
Journal Articles
- Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) PandemicLauren Sinnenberg, Nosheen Reza, Michelle M Kittleson, Veli K Topkara, Maryjane A Farr, JAMA Cardiology
- VA‐ECMO for Cardiogenic Shock in the Contemporary Era of Heart Transplantation: Which Patients Should Be Urgently Transplanted?Yoshifumi Naka, Maryjane A Farr, Koji Takeda, Paolo Colombo, Hiroo Takayama, Arthur R Garan, Veli K Topkara, Clinical Transplantation
Authored Content
- Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) PandemicJuly 2020
- Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) PandemicJuly 2020
- Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
- Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
- Prognostic Impact of Pulmonary Artery Pulsatility Index (PAPi) in Patients with Advanced Heart Failure: Insights from the ESCAPE TrialMarch 2018
- Join now to see all
Press Mentions
- LV Unloading and Myocardial Recovery : An Exciting Future in the Continuum of Remission to RecoveryMarch 30th, 2023
- Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist DevicesJune 2nd, 2016
- International Genome-Wide Association Study Consortium Identifies Novel Loci Associated with Blood Pressure in Children and AdolescentsMarch 11th, 2016
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: